Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors

Histamine H3 Receptor Antagonist in Treatments of Cognition Disorders

The first potent nonimidazole H3 receptor antagonist (pKi=8.40)

Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), Showing Efficacy in Neuropathic Pain Amelioration

Novel potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor, improving survival in Ras-driven acute myeloid leukemia

Dual inhibitor of fatty acid amide hydrolase (FAAH) and α/β hydrolase domain 6 (ABHD6)

Stereoisomer of UCN-01, inhibiting protein kinase C with a slightly reduced potency than UCN-01

Novel dual inhibitor of dihydrofolate reductase (DHFR) and its functional analog, Rv2671

Fluorescent excitatory amino acid transporter subtype 1 (EAAT1) selective inhibitor

Potent and selective 11ß-HSD1 inhibitor, improving memory, including after intracerebroventricular drug administration to the central nervous system alone

Novel selective delta-opioid receptor agonist

Novel Nicotinic Acetylcholine Receptor Antagonist, Inhibiting Nicotine Reward and Decreases Anxiety and Decreasing Ethanol Intake in Alcohol-Preferring Rats

Novel inhibitor of UGM, impeding C. glutamicum growth

Novel inhibitor of UGM, impeding C. glutamicum growth

Novel potent human immunodeficiency virus type 1 (HIV-1) protease inhibito

Selective NEP inhibitor for treatment of the symptoms of Female sexual arousal disorder (FSAD)

Selective NEP inhibitor for treatment of the symptoms of Female sexual arousal disorder (FSAD)

Potent VMAT2 inhibitor

Novel chemically stable fluorescent marker of the ureter

Novel Vaccine Adjuvant for Mycobacterium tuberculosis

Novel potent and selective dual PLK1 and BRD4 inhibitor, inducing apoptosis in pediatric tumor cell lines, leading to significant tumor regression

Novel, Potent, and Selective CBP/P300 Inhibitor